Cargando…
Cilostazol Activates Function of Bone Marrow-Derived Endothelial Progenitor Cell for Re-endothelialization in a Carotid Balloon Injury Model
BACKGROUND: Cilostazol(CLZ) has been used as a vasodilating anti-platelet drug clinically and demonstrated to inhibit proliferation of smooth muscle cells and effect on endothelial cells. However, the effect of CLZ on re-endothelialization including bone marrow (BM)-derived endothelial progenitor ce...
Autores principales: | Kawabe-Yako, Rie, Masaaki, Ii, Masuo, Osamu, Asahara, Takayuki, Itakura, Toru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171459/ https://www.ncbi.nlm.nih.gov/pubmed/21931795 http://dx.doi.org/10.1371/journal.pone.0024646 |
Ejemplares similares
-
Correction: Cilostazol Activates Function of Bone Marrow-Derived Endothelial Progenitor Cell for Re-endothelialization in a Carotid Balloon Injury Model
por: Kawabe-Yako, Rie, et al.
Publicado: (2012) -
Improved Culture-Based Isolation of Differentiating Endothelial Progenitor Cells from Mouse Bone Marrow Mononuclear Cells
por: Sekiguchi, Haruki, et al.
Publicado: (2011) -
CD34(+) Cells Represent Highly Functional Endothelial Progenitor Cells in Murine Bone Marrow
por: Yang, Junjie, et al.
Publicado: (2011) -
Functional disruption of α4 integrin mobilizes bone marrow–derived endothelial progenitors and augments ischemic neovascularization
por: Qin, Gangjian, et al.
Publicado: (2006) -
Characterization of Endothelial Progenitor Cell: Past, Present, and Future
por: Salybekov, Amankeldi A., et al.
Publicado: (2022)